Catalyst Pharmaceuticals
CPRX
$14.89
Share price
1.43%
Change (1 day)
-7.05%
Change (1 year)
Categories
Catalyst Pharmaceuticals (CPRX) - Total debt
Total debt on the balance sheet as of December 2023 : $3.55 M
According to Catalyst Pharmaceuticals's latest financial reports the company's total debt is $3.55 M. A company’s total debt is the sum of all current and non-current debts.
Catalyst Pharmaceuticals - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $3.55 M | -8.65% |
| 2022-12-31 | $3.89 M | -7.33% |
| 2021-12-31 | $4.2 M | 14389.66% |
| 2020-12-31 | $0.02 M | -96.94% |
| 2019-12-31 | $0.94 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 824,527.50% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 1,991,606.49% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | 439,259.01% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $1.39 B | 39,169.33% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.18 B | 5,131.63% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 30,705.45% | 🇺🇸 USA |